{
    "clinical_study": {
        "@rank": "46853", 
        "arm_group": [
            {
                "arm_group_label": "Cilostazol", 
                "arm_group_type": "Active Comparator", 
                "description": "Capsule of Cilostazol 200 mg are taken orally on each study day"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "A capsule of placebo containing starch are taken orally on each study day."
            }
        ], 
        "brief_summary": {
            "textblock": "We will use Cilostazol as a tool to investigate its headache inducing effects in migraine\n      patients."
        }, 
        "brief_title": "The Headache Inducing Effects of Cilostazol on Migraine Patients", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Migraine", 
        "condition_browse": {
            "mesh_term": [
                "Headache", 
                "Migraine Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosed with migraine without aura according to the IHS criteria from 2004.\n\n          -  Healthy besides migraine\n\n        Exclusion Criteria:\n\n          -  Tension-type headache more than 3 days per month\n\n          -  Other types of primary headaches\n\n          -  Pregnancy\n\n          -  History of vascular diseases or psychiatric diseases."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "14", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01841827", 
            "org_study_id": "H-2-2013-033"
        }, 
        "intervention": [
            {
                "arm_group_label": "Cilostazol", 
                "intervention_name": "Cilostazol", 
                "intervention_type": "Drug", 
                "other_name": "Pletal"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Cilostazol"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 10, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "state": "Glostrup", 
                    "zip": "2600"
                }, 
                "name": "Danish Headache Center & Department of Neurology"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Headache Inducing Effects of Cilostazol on Migraine Patients", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Denmark: Danish Health and Medicines Authority", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Rectruitment of 14 patients will be done during April and May. Experiments will be carried out in May and June. Each experiment day takes 1\u00bd hour. Data analysis will be done in June and July. Final data will be presented within 6 months.", 
            "measure": "The incidens of headache or migraine after adminstration of Cilostazol in migraine patients compared to placebo.", 
            "safety_issue": "No", 
            "time_frame": "Outcome measure will be done within 3 month. Final data will be presented within 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01841827"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Danish Headache Center", 
            "investigator_full_name": "Song Guo", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Danish Headache Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Danish Headache Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}